fda compounding semaglutide update today The issued an alert to healthcare providers, compound pharmacies, and patients about recent overdoses associated with compounded injectable semaglutide, leading to the dosing of five to 20 times… FDA Warns on Certain Forms
Description
Research Areas (20242026) Direct Clinical Connections Active research in 2026 is investigating the long-term durability of Janumet XR

Recent pharmacovigilance has also identified signals for intestinal obstruction (ileus) with some GLP-1 receptor agonists

More Than Medication: A Whole-Body Approach At Somerset Medical, we dont just hand you a prescription and send you on your way

Trajectory of weight regain after cessation of GLP-1 receptor agonists: A systematic review and nonlinear meta-regression